Penumbra (NYSE:PEN) just reported results for the second quarter of 2024. Penumbra reported earnings per share of 64 cents. This was above the analyst estimate for EPS of 56 cents. The company ...

Medical device company Penumbra (NYSE:PEN) reported Q1 CY2025 results beating ... 2.7% beat) Adjusted EPS: $0.83 vs analyst estimates of $0.67 (24.4% beat) Adjusted EBITDA: $59.6 million vs ...

Penumbra (NYSE:PEN) just reported results for the first quarter of 2024. Penumbra reported earnings per share of 41 cents. This was above the analyst estimate for EPS of 38 cents. The company ...